Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Component of octagam?

See the DrugPatentWatch profile for octagam

What is Octagam?

Octagam is a 5% intravenous immunoglobulin (IVIG) solution made from human plasma. It contains purified immunoglobulin G (IgG) antibodies pooled from thousands of healthy donors to treat primary immunodeficiency diseases and other conditions requiring immune support.[1]

Main Active Component

The primary active ingredient is human normal immunoglobulin G (IgG), at a concentration of 50 mg/mL (5% solution). IgG makes up over 95% of the total immunoglobulins, with a typical distribution of:
- IgG1: ~60%
- IgG2: ~32%
- IgG3: ~7%
- IgG4: ~1%

This mirrors the IgG subclass ratios in normal human plasma.[1][2]

Stabilizers and Excipients

Octagam includes:
- Maltose (10%, or 100 mg/mL) as the main stabilizer.
- Sodium chloride (0.9%, or 9 mg/mL) for isotonicity.
- No preservatives; it's sterile-filtered.

The formulation avoids sugars like sucrose or glycine, reducing risks like renal issues in some patients.[1]

How Octagam is Produced

Plasma is sourced from screened U.S. donors, cold-ethanol fractionated (Cohn-Oncley process), treated with solvent-detergent for viral inactivation, and nanofiltered (35 nm pores) for additional pathogen removal. Final IgG purity exceeds 98%.[1][2]

Differences from Other IVIGs

Compared to competitors like Gammagard (glycine-stabilized) or Privigen (sucrose-stabilized), Octagam's maltose stabilizer may lower osmotic nephrosis risk. All share similar IgG profiles but vary in manufacturing and additives.[2]

Common Patient Questions on Components

Patients often ask if Octagam contains latex (no), albumin (trace amounts only), or IgA (minimal, <50 mcg/mL, safe for most IgA-deficient patients). Trace proteins like IgM and IgA are below 5 mg/mL.[1]

[1]: Octagam Prescribing Information (FDA)
[2]: DrugPatentWatch.com - Octagam





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy